Physician profile
Stuart B Taylor
NPI 1710982566
$1,069.15
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.25 · 2020: $53.66 · 2021: $289 · 2022: $83.00 · 2023: $367 · 2024: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $181.00 | 2019-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Tris Pharma INC | $148.26 | 2023-2024 | Dyanavel Xr, Quillivant, Quillichew Er |
| Glaxosmithkline, LLC. | $97.25 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $76.85 | 2021 | |
| Sanofi Pasteur INC. | $74.79 | 2021-2024 | |
| Sobi, INC | $73.69 | 2021-2023 | |
| Ironshore Pharmaceuticals INC. | $72.42 | 2019-2023 | Jornay Pm |
| Cumberland Pharmaceuticals, INC. | $51.51 | 2021-2024 | Kristalose |
| Supernus Pharmaceuticals, INC. | $47.70 | 2021 | |
| Pfizer INC. | $40.20 | 2022-2023 | |
| Neos Therapeutics, LP | $38.02 | 2024 | Adzenys Xr-Odt |
| Kaleo, INC. | $37.24 | 2023 | Auvi-Q |
| Corium, LLC | $31.95 | 2023 | Azstarys |
| Seqirus USA INC | $28.41 | 2021 | |
| Avion Pharmaceuticals | $19.16 | 2023 | Methylphenidate Hydrochloride |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $17.65 | 2023 | Flumist Quadrivalent |
| Cranial Technologies, INC | $17.15 | 2024 | Doc Band |
| Alexion Pharmaceuticals, INC. | $15.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.